Clinical Trials Browser

Phase 2 × Recruiting × Pyruvic Acid × Clear all

NCT06384222 2025-12-30

Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone

Phase 2 Recruiting

Prostatic Neoplasms

NCT06645691 2024-12-06

POLARIC-13

Phase 2 Recruiting

Cardiovascular Diseases, Heart Failure, Metabolic Syndrome